Exact Mass: 429.2341
Exact Mass Matches: 429.2341
Found 500 metabolites which its exact mass value is equals to given mass value 429.2341
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Melagatran
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AE - Direct thrombin inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins
Guan-fu base A
Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2]. Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2].
mebeverine
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Melagatran
Sarpogrelate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
mebeverine
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants CONFIDENCE standard compound; INTERNAL_ID 2744 CONFIDENCE standard compound; INTERNAL_ID 8523
2-amino-3-[[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid
Yusurimin A|Yuzurimin A|Yuzurimin A (Desacetoxy-yuzurimin)
alpha-Methyl-1,4-dihydro-1-(acetoxymethyl)-4-oxoquinoline-2-decan-1-ol acetate
(-)N-(12-Acetoxy)jasmonoyl-phenylalaninmethylester
acehytisine
Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2]. Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2].
C25H35NO5_Spiro[2H-furo[2,3-e]isoindole-2,1(2H)-naphthalen]-6(3H)-one, 3,4,4a,5,6,7,7,8,8,8a-decahydro-4,6-dihydroxy-7-(2-hydroxyethyl)-2,5,5,8a-tetramethyl-, (2R,2R,6R,8aS)
C21H35NO6S_Cysteine, S-[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxooxacyclotetradeca-6,9-dien-4-yl]
(3R,7R,8R,8aS)-3,4-dihydroxy-7-(2-hydroxyethyl)-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-6-one
(2R,2R,4aS,6R,8aS)-4,6-dihydroxy-7-(2-hydroxyethyl)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,7,8,8,8a-decahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-6(3H)-one
2-amino-3-[[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid_major
Ala Asp Lys Pro
Ala Asp Pro Lys
Ala Ile Ile Asn
Ala Ile Leu Asn
Ala Ile Asn Ile
Ala Ile Asn Leu
Ala Ile Gln Val
Ala Ile Val Gln
Ala Lys Asp Pro
Ala Lys Pro Asp
Ala Leu Ile Asn
Ala Leu Leu Asn
Ala Leu Asn Ile
Ala Leu Asn Leu
Ala Leu Gln Val
Ala Leu Val Gln
Ala Asn Ile Ile
Ala Asn Ile Leu
Ala Asn Leu Ile
Ala Asn Leu Leu
Ala Pro Asp Lys
Ala Pro Lys Asp
Ala Pro Arg Ser
Ala Pro Ser Arg
Ala Gln Ile Val
Ala Gln Leu Val
Ala Gln Val Ile
Ala Gln Val Leu
Ala Arg Pro Ser
Ala Arg Ser Pro
Ala Ser Pro Arg
Ala Ser Arg Pro
Ala Val Ile Gln
Ala Val Leu Gln
Ala Val Gln Ile
Ala Val Gln Leu
Asp Ala Lys Pro
Asp Ala Pro Lys
Asp Lys Ala Pro
Asp Lys Pro Ala
Asp Pro Ala Lys
Asp Pro Lys Ala
Glu Gly Lys Pro
Glu Gly Pro Lys
Glu Lys Gly Pro
Glu Lys Pro Gly
Glu Pro Gly Lys
Glu Pro Lys Gly
Gly Glu Lys Pro
Gly Glu Pro Lys
Gly Ile Ile Gln
Gly Ile Leu Gln
Gly Ile Gln Ile
Gly Ile Gln Leu
Gly Lys Glu Pro
Gly Lys Pro Glu
Gly Leu Ile Gln
Gly Leu Leu Gln
Gly Leu Gln Ile
Gly Leu Gln Leu
Gly Pro Glu Lys
Gly Pro Lys Glu
Gly Pro Arg Thr
Gly Pro Thr Arg
Gly Gln Ile Ile
Gly Gln Ile Leu
Gly Gln Leu Ile
Gly Gln Leu Leu
Gly Arg Pro Thr
Gly Arg Thr Pro
Gly Thr Pro Arg
Gly Thr Arg Pro
Ile Ala Ile Asn
Ile Ala Leu Asn
Ile Ala Asn Ile
Ile Ala Asn Leu
Ile Ala Gln Val
Ile Ala Val Gln
Ile Gly Ile Gln
Ile Gly Leu Gln
Ile Gly Gln Ile
Ile Gly Gln Leu
Ile Ile Ala Asn
Ile Ile Gly Gln
Ile Ile Asn Ala
Ile Ile Gln Gly
Ile Leu Ala Asn
Ile Leu Gly Gln
Ile Leu Asn Ala
Ile Leu Gln Gly
Ile Asn Ala Ile
Ile Asn Ala Leu
Ile Asn Ile Ala
Ile Asn Leu Ala
Ile Asn Pro Ser
Ile Asn Ser Pro
Ile Pro Asn Ser
Ile Pro Ser Asn
Ile Gln Ala Val
Ile Gln Gly Ile
Ile Gln Gly Leu
Ile Gln Ile Gly
Ile Gln Leu Gly
Ile Gln Val Ala
Ile Ser Asn Pro
Ile Ser Pro Asn
Ile Val Ala Gln
Ile Val Gln Ala
Lys Ala Asp Pro
Lys Ala Pro Asp
Lys Asp Ala Pro
Lys Asp Pro Ala
Lys Glu Gly Pro
Lys Glu Pro Gly
Lys Gly Glu Pro
Lys Gly Pro Glu
Lys Pro Ala Asp
Lys Pro Asp Ala
Lys Pro Glu Gly
Lys Pro Gly Glu
Lys Pro Ser Val
Lys Pro Val Ser
Lys Ser Pro Val
Lys Ser Val Pro
Lys Val Pro Ser
Lys Val Ser Pro
Leu Ala Ile Asn
Leu Ala Leu Asn
Leu Ala Asn Ile
Leu Ala Asn Leu
Leu Ala Gln Val
Leu Ala Val Gln
Leu Gly Ile Gln
Leu Gly Leu Gln
Leu Gly Gln Ile
Leu Gly Gln Leu
Leu Ile Ala Asn
Leu Ile Gly Gln
Leu Ile Asn Ala
Leu Ile Gln Gly
Leu Leu Ala Asn
Leu Leu Gly Gln
Leu Leu Asn Ala
Leu Leu Gln Gly
Leu Asn Ala Ile
Leu Asn Ala Leu
Leu Asn Ile Ala
Leu Asn Pro Ser
Leu Asn Ser Pro
Leu Pro Asn Ser
Leu Pro Ser Asn
Leu Ser Asn Pro
Leu Ser Pro Asn
Asn Ile Pro Ser
Asn Ile Ser Pro
Asn Leu Pro Ser
Asn Leu Ser Pro
Asn Pro Ile Ser
Asn Pro Leu Ser
Asn Pro Ser Ile
Asn Pro Ser Leu
Asn Pro Thr Val
Asn Pro Val Thr
Asn Ser Ile Pro
Asn Ser Leu Pro
Asn Ser Pro Ile
Asn Ser Pro Leu
Asn Thr Pro Val
Asn Thr Val Pro
Asn Val Pro Thr
Asn Val Thr Pro
Pro Ala Asp Lys
Pro Ala Lys Asp
Pro Ala Arg Ser
Pro Ala Ser Arg
Pro Asp Ala Lys
Pro Asp Lys Ala
Pro Glu Gly Lys
Pro Glu Lys Gly
Pro Gly Glu Lys
Pro Gly Lys Glu
Pro Gly Arg Thr
Pro Gly Thr Arg
Pro Ile Asn Ser
Pro Ile Ser Asn
Pro Lys Ala Asp
Pro Lys Asp Ala
Pro Lys Glu Gly
Pro Lys Gly Glu
Pro Leu Asn Ser
Pro Leu Ser Asn
Pro Asn Ile Ser
Pro Asn Leu Ser
Pro Asn Ser Ile
Pro Asn Ser Leu
Pro Asn Thr Val
Pro Asn Val Thr
Pro Gln Ser Val
Pro Gln Val Ser
Pro Arg Ala Ser
Pro Arg Gly Thr
Pro Arg Ser Ala
Pro Arg Thr Gly
Pro Ser Ala Arg
Pro Ser Ile Asn
Pro Ser Leu Asn
Pro Ser Asn Ile
Pro Ser Asn Leu
Pro Ser Gln Val
Pro Ser Arg Ala
Pro Ser Val Gln
Pro Thr Gly Arg
Pro Thr Asn Val
Pro Thr Arg Gly
Pro Thr Val Asn
Pro Val Asn Thr
Pro Val Gln Ser
Pro Val Ser Gln
Pro Val Thr Asn
Gln Pro Ser Val
Gln Pro Val Ser
Gln Ser Pro Val
Gln Ser Val Pro
Gln Val Pro Ser
Gln Val Ser Pro
Arg Ala Pro Ser
Arg Ala Ser Pro
Arg Gly Pro Thr
Arg Gly Thr Pro
Arg Pro Ala Ser
Arg Pro Gly Thr
Arg Pro Ser Ala
Arg Pro Thr Gly
Arg Ser Ala Pro
Arg Ser Pro Ala
Arg Thr Gly Pro
Arg Thr Pro Gly
Ser Ala Pro Arg
Ser Ala Arg Pro
Ser Ile Asn Pro
Ser Ile Pro Asn
Ser Leu Asn Pro
Ser Leu Pro Asn
Ser Asn Ile Pro
Ser Asn Leu Pro
Ser Asn Pro Ile
Ser Asn Pro Leu
Ser Pro Ala Arg
Ser Pro Ile Asn
Ser Pro Leu Asn
Ser Pro Asn Ile
Ser Pro Asn Leu
Ser Pro Gln Val
Ser Pro Arg Ala
Ser Pro Val Gln
Ser Gln Pro Val
Ser Gln Val Pro
Ser Arg Ala Pro
Ser Arg Pro Ala
Ser Val Pro Gln
Ser Val Gln Pro
Thr Gly Pro Arg
Thr Gly Arg Pro
Thr Asn Pro Val
Thr Asn Val Pro
Thr Pro Gly Arg
Thr Pro Asn Val
Thr Pro Arg Gly
Thr Pro Val Asn
Thr Arg Gly Pro
Thr Arg Pro Gly
Thr Val Asn Pro
Thr Val Pro Asn
Val Asn Pro Thr
Val Asn Thr Pro
Val Pro Asn Thr
Val Pro Gln Ser
Val Pro Ser Gln
Val Pro Thr Asn
Val Gln Pro Ser
Val Gln Ser Pro
Val Ser Pro Gln
Val Ser Gln Pro
Val Thr Asn Pro
Val Thr Pro Asn
2-hydroxyethyl 2-methylprop-2-enoate,2-methylidenehexanoate,methyl 2-methylprop-2-enoate,prop-2-enoic acid
3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole
1-(4-Diethylaminophenyl)-1,4,4-triphenyl-1,3-butadiene
1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)-1H-1,2,3-TRIAZOLE-4-CARBOTHIALDEHYDE
(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-[(1S)-1-cyclohexylethyl]pyrrolidine-1-carboxamide
ON-123300
Narazaciclib (ON123300), a strong and brain-penetrant[1] multi-kinase inhibitor, inhibits CDK4 (IC50=3.9 nM), Ark5 (IC50=5 nM), PDGFRβ (IC50=26 nM), FGFR1 (IC50=26 nM), RET (IC50=9.2 nM), and FYN (IC50=11 nM). Single agent Narazaciclib causes a dose-dependent suppression of phosphorylation of Akt as well as activation of Erk in brain tumors[2]. Narazaciclib inhibits CDK6 with an IC50 of 9.82 nM[3].
Evobrutinib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent
7-[2(S)-[3(R)-Hydroxy-4-[3-(trifluoromethyl)phenyl]butyl]-5-oxopyrrolidin-1-yl]heptanoic acid
N-[(3-acetamidophenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Sarpogrelate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
3,4-dihydroxy-7-(2-hydroxyethyl)-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-6-one
N-(4-phenylmethoxyphenyl)-3-[4-(phenylmethyl)-1-piperazinyl]propanamide
1-acetyl-6-[2-(4-ethyl-1-piperazinyl)-2-oxoethoxy]-4-spiro[3,4-dihydro-2H-1-benzopyran-2,4-piperidine]one
1-[2-[[4,6-Bis(4-morpholinyl)-1,3,5-triazin-2-yl]oxy]ethyl]-3-phenylurea
N-[1-methyl-2-[2-(4-phenyl-1-piperazinyl)ethyl]-5-benzimidazolyl]-2-furancarboxamide
(12S,13R,16R,8S)-13-methoxy-6,8,10-trimethyl-5,9-dioxo-13,14,15,16-tetrahydro-12H-3-oxa-6,10-diaza-1(2,6)-pyrana-4(1,2)-benzenacyclododecaphane-44-carbonitrile
(12S,13R,16R,8S)-13-methoxy-6,8,10-trimethyl-5,9-dioxo-13,14,15,16-tetrahydro-12H-3-oxa-6,10-diaza-1(2,6)-pyrana-4(1,2)-benzenacyclododecaphane-46-carbonitrile
[(3aR,4S,9bS)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
(1S,19S,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19S,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,14S,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14S,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19S,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19S,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19R,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1R,14S,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14S,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14S,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,19S,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1R,14S,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14S,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14S,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14S,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14R,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14S,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,13S,18R,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1S,13R,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1R,13R,18R,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1S,13R,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13R,18S,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13S,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1S,19R,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1S,19S,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19S,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19S,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1R,19R,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,19R,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1R,19S,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1S,19R,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1S,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(2R,3S)-8-(4-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(1R,19R,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1R,14R,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14S,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14S,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14S,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14S,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14R,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14R,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14R,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14S,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14S,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,13R,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1S,13S,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1R,13S,18S,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1R,13S,18R,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1R,13R,18S,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1S,13S,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13R,18R,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13S,18R,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13S,18R,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1S,19R,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19R,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19R,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19S,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19R,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1R,19S,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,19S,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,19R,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,19S,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,19S,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1R,19S,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1S,19S,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1R,19R,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1R,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
[(3aS,4R,9bR)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
[(3aS,4S,9bR)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
3-[4-[(1S,5R)-3-[(2-fluorophenyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
3-[4-(2-Benzyl-5-tert-butylpyrazole-3-carbonyl)piperazin-1-yl]pyrazine-2-carbonitrile
2-amino-3-[[(6Z,9Z)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid
asnovolin I(1-)
A monocarboxylic acid anion that is the conjugate base of asnovolin I resulting from the deprotonation of the carboxy group. Major microspecies at pH 7.3.
BML-280
BML-280 (VU0285655-1) is a potent and selective phospholipase D2 (PLD2) inhibitor. BML-280 has the ability to prevent caspase-3 cleavage and reduction in cell viability induced by high glucose. BML-280 can be used for rheumatoid arthritis research[1][2].